<DOC>
	<DOCNO>NCT02284243</DOCNO>
	<brief_summary>The primary objective study evaluate analgesic efficacy , Post-Operative Day ( POD ) 1 , DEX-IN compare placebo , use sum pain intensity difference first 48 hour ( SPID48 ) subject acute moderate severe pain follow unilateral bunionectomy .</brief_summary>
	<brief_title>Placebo-Controlled Evaluation Intranasal Dexmedetomidine Postoperative Analgesia Following Bunionectomy Surgery</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Voluntarily provide write informed consent . Male female 18 70 year age , inclusive . Be schedule undergo primary unilateral first metatarsal bunionectomy repair Be American Society Anesthesiology ( ASA ) physical class 1 2 . Female subject eligible follow apply : Not pregnant ; Not lactate ; Not plan become pregnant study ; Be surgically sterile ; least two year post menopausal ; monogamous partner surgically sterile ; practice doublebarrier contraception ; practice abstinence ; use insertable , injectable , transdermal , combination oral contraceptive . Male subject must surgically sterile commit use reliable method birth control Have body mass index â‰¤35 kg/m2 Be able understand study procedure , comply study procedure , agree participate study program . Have know allergy dexmedetomidine excipient DEXIN/placebo peri postoperative medication use study . Have clinically significant abnormal clinical laboratory test value . Have history positive test result HIV , hepatitis B C. Have history clinical manifestation significant renal , hepatic , cardiovascular , metabolic , neurologic , psychiatric , condition would preclude participation study . Have history migraine frequent headache , seizure , currently take anticonvulsant . Have another painful physical condition may confound assessment post operative pain . Have history syncope syncopal attack . Have evidence clinically significant 12 lead ECG abnormality . Have history alcohol abuse ( regularly drink &gt; 4 unit alcohol per day ; 8 oz . beer , 3 oz . wine , 1 oz . spirit ) prescription/illicit drug abuse.. Have positive result urine drug screen alcohol breath test indicative illicit drug alcohol abuse . Have history evidence orthostatic hypotension . Have rest heart rate &lt; 50 beat per minute systolic blood pressure &lt; 100mmHg . Have receive receive chronic opioid therapy define great 15 morphine equivalent unit per day great 3 7 day per week onemonth period within 12 month . Use concurrent therapy could interfere evaluation efficacy safety , drug investigator 's opinion may exert significant analgesic property act synergistically DEXIN . Unable discontinue medication , stable dose least 14 day prior schedule bunionectomy procedure , within 5 half life specific prior medication ( , half life know , within 48 hour ) dose . Have utilize intranasal medication within precede 10 day . Have sign history significant rhinitis rhinorrhea ( constant chronic ) , nasal polyp , mucosal lesion nostril , postnasal drip etiology ( constant chronic ) , nasal ulcer , septal perforation deviation , nasal surgery , anosmia , nasal piercings , frequent nosebleed nasal pathology , sufficient interfere IN drug delivery . Have upper respiratory tract infection within 14 day screen . Have utilized corticosteroid , either systemically , inhalational either intranasally oral , intraarticular injection , within 14 day prior study . Have receive investigational product within 30 day dose study medication . Have previously receive DEXIN clinical trial , bunionectomy last 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Bunion</keyword>
	<keyword>Bunionectomy</keyword>
	<keyword>Pain</keyword>
	<keyword>Analgesia</keyword>
	<keyword>dexmedetomidine</keyword>
	<keyword>intranasal</keyword>
</DOC>